Related Experiment Video
Updated: Oct 11, 2026

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
Host genetic determinants of neurological disease induced by Cas-Br-M murine leukemia virus
Abstract:
Cas-Br-M is an ecotropic murine leukemia virus (MuLV) of wild-mouse origin that causes neurogenic hind-limb paralysis. By virtue of its N-tropism, the virus replicates well in tissues of mice bearing the n but not the b allele at the Fv-1 locus. To determine if different Fv-1n strains of mice were equally susceptible to virus-induced neurological disease, we inoculated NFS, C3H, DBA/2, CBA, AKR, C58, and NZB mice at birth with Cas-Br-M murine leukemia virus and observed them for the development of tremor and hind-limb paralysis. Three patterns of disease were observed: NFS and C3H mice developed disease within 3 months postinoculation; DBA/2 and CBA mice became affected between 8 and 15 months postinoculation; and no disease was observed in AKR, C58, or NZB mice up to 15 months after infection with Cas-Br-M murine leukemia virus. Studies of genetic crosses between intermediate-latency (DBA/2) or long-latency (AKR) strains with short-latency (NFS) strains showed that intermediate latency and long latency were semidominant traits determined by two or more interacting but independently assorting loci. These genes appear to determine the rate at which the virus replicates and at which viral gene products accumulate in the central nervous system.
Insights
Cas-Br-M murine leukemia virus causes hind-limb paralysis in mice. Genetic factors influence disease onset, with latency being a semidominant trait controlled by multiple genes affecting viral replication.
Area of Science:
- Virology
- Immunogenetics
- Neuroscience
Background:
- Cas-Br-M is an ecotropic murine leukemia virus (MuLV) causing neurogenic hind-limb paralysis.
- Its N-tropism affects replication in mice with the Fv-1n allele.
Purpose of the Study:
- To investigate susceptibility to Cas-Br-M-induced neurological disease across different Fv-1n mouse strains.
- To understand the genetic basis of disease latency.
Main Methods:
- Inoculation of newborn mice (NFS, C3H, DBA/2, CBA, AKR, C58, NZB) with Cas-Br-M MuLV.
- Observation for tremor and hind-limb paralysis development.
- Genetic crosses between short-, intermediate-, and long-latency strains.
Main Results:
- Three disease patterns observed: short (NFS, C3H), intermediate (DBA/2, CBA), and long/no disease (AKR, C58, NZB).
- Latency traits were semidominant, controlled by multiple independently assorting loci.
- Genes likely regulate viral replication rate and CNS viral gene product accumulation.
Conclusions:
- Mouse strain genetics significantly impact susceptibility and latency of Cas-Br-M-induced neurological disease.
- Multiple interacting genes control disease progression, influencing viral dynamics in the central nervous system.
More Related Videos
05:45In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
12:04Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023